Innovative Autoimmune Solutions SetPoint Medical’s focus on neurostimulation platforms that activate anti-inflammatory pathways presents a significant opportunity to target healthcare providers specializing in autoimmune and rheumatoid arthritis treatments, particularly those interested in minimally invasive and neuromodulation therapies.

Recent Funding & Growth With recent financing rounds totaling over 235 million dollars, including substantial investments from Boston Scientific and Abbott, the company is poised for rapid commercial expansion, offering sales teams a chance to engage early with a fast-growing medical tech innovator in the autoimmune space.

Strategic Partnerships Collaborations with government services and participation in major conferences such as the ACR Convergence create opportunities to connect with key decision-makers, researchers, and healthcare institutions seeking cutting-edge therapies for chronic autoimmune diseases.

Market Presence & Visibility Participation in high-profile industry events and the company’s active communication on clinical advancements and product launches signal an increasing market presence, useful for positioning and outreach to early adopters and clinical trial sites.

Potential Clinical Adoption Therapies targeting neuroimmune modulation for rheumatoid arthritis are gaining momentum, offering opportunities to collaborate with hospitals, specialty clinics, and healthcare systems that are adopting or exploring innovative treatments for autoimmune conditions.